This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
11/27/15 - 10:34:22 AM ET (BATS BZX Real-time Price)
Div Yield: --
BTX Day's Range
BTX 52 Week Range
BTX Business Summary
BioTime, Inc., a biotechnology company, engages in the research and product development in the field of regenerative medicine.View BTX key stats
BioTime Inc - BTX - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates BioTime Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate BIOTIME INC (BTX) a SELL. This is driven by a few notable weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow.